[{"id":"ae8410e8-deea-4756-9774-18fb45fe7247","acronym":"","url":"https://clinicaltrials.gov/study/NCT04758897","created_at":"2021-02-17T14:01:03.261Z","updated_at":"2024-07-02T16:36:31.185Z","phase":"Phase 1","brief_title":"Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors","source_id_and_acronym":"NCT04758897","lead_sponsor":"CNBG-Virogin Biotech (Shanghai) Ltd.","biomarkers":" PD-L1 • CD8 • PD-1 • CD4 • IL15 • NECTIN2","pipe":"","alterations":" ","tags":["PD-L1 • CD8 • PD-1 • CD4 • IL15 • NECTIN2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e VG161"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 04/14/2021","start_date":" 04/14/2021","primary_txt":" Primary completion: 03/14/2022","primary_completion_date":" 03/14/2022","study_txt":" Completion: 12/01/2022","study_completion_date":" 12/01/2022","last_update_posted":"2021-04-27"}]